🔎 Trials Near Me

Home › Non-Muscle Invasive Bladder Cancer › Virginia

Pag-aaral pangklinika para sa Non-Muscle Invasive Bladder Cancer sa Virginia

6 pag-aaral para sa Non-Muscle Invasive Bladder Cancer ang naghahanap ng mga kalahok sa mga site sa Virginia.

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • VCU Massey Comprehensive Cancer Center, Richmond
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • Urology of Virginia ( Site 0125), Virginia Beach
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06833073

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Virginia Urology, Richmond
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05951179

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • University of Virginia Comprehensive Cancer Center, Charlottesville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT04752722

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

  • Potamac Urology Center, Alexandria
Nagre-recruitPhase 1/2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06800963

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

  • University of Virginia, Charlottesville
Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Dis 16, 2024 · NCT05790850

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.